Business Description
Alar Pharmaceuticals Inc
ISIN : TW0006785009
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2396.25 | |||||
Equity-to-Asset | 0.97 | |||||
Interest Coverage | 7168.3 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 143.57 | |||||
Beneish M-Score | 520.35 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 781.7 | |||||
3-Year Book Growth Rate | 14.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.73 | |||||
9-Day RSI | 49.42 | |||||
14-Day RSI | 46.03 | |||||
6-1 Month Momentum % | 51 | |||||
12-1 Month Momentum % | 78.01 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 35.07 | |||||
Quick Ratio | 35.07 | |||||
Cash Ratio | 34.99 | |||||
Days Sales Outstanding | 0.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -8.96 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 80.96 | |||||
Net Margin % | 87.64 | |||||
FCF Margin % | 59.97 | |||||
ROE % | 41.47 | |||||
ROA % | 36.4 | |||||
ROIC % | 247.4 | |||||
ROC (Joel Greenblatt) % | 3424.44 | |||||
ROCE % | 42.83 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 37.51 | |||||
PE Ratio without NRI | 37.51 | |||||
PS Ratio | 32.8 | |||||
PB Ratio | 6.97 | |||||
Price-to-Tangible-Book | 6.97 | |||||
Price-to-Free-Cash-Flow | 54.9 | |||||
Price-to-Operating-Cash-Flow | 54.72 | |||||
EV-to-EBIT | 36.24 | |||||
EV-to-EBITDA | 35.95 | |||||
EV-to-Revenue | 32.91 | |||||
EV-to-FCF | 57.25 | |||||
Price-to-Graham-Number | 3.41 | |||||
Price-to-Net-Current-Asset-Value | 7.16 | |||||
Price-to-Net-Cash | 7.18 | |||||
Earnings Yield (Greenblatt) % | 2.75 | |||||
FCF Yield % | 1.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Alar Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 469.272 | ||
EPS (TTM) (NT$) | 7.198 | ||
Beta | 0.89 | ||
Volatility % | 86.42 | ||
14-Day RSI | 46.03 | ||
14-Day ATR (NT$) | 16.437143 | ||
20-Day SMA (NT$) | 269.325 | ||
12-1 Month Momentum % | 78.01 | ||
52-Week Range (NT$) | 116 - 465 | ||
Shares Outstanding (Mil) | 66.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Alar Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Alar Pharmaceuticals Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Alar Pharmaceuticals Inc Frequently Asked Questions
What is Alar Pharmaceuticals Inc(ROCO:6785)'s stock price today?
When is next earnings date of Alar Pharmaceuticals Inc(ROCO:6785)?
Does Alar Pharmaceuticals Inc(ROCO:6785) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |